The GLP‐1 Receptor Agonist Liraglutide Promotes Anticancer Activities in MCF7 Breast and PC‐3 Prostate Cancer Cells by Modulating Glycolysis, Oxidative Stress and Adipokines.
Saved in:
| Title: | The GLP‐1 Receptor Agonist Liraglutide Promotes Anticancer Activities in MCF7 Breast and PC‐3 Prostate Cancer Cells by Modulating Glycolysis, Oxidative Stress and Adipokines. |
|---|---|
| Authors: | Refaat, Bassem1 (AUTHOR) barefaat@uqu.edu.sa, Elzubier, Mohamed E.2 (AUTHOR), Aslam, Akhmed1 (AUTHOR), Idris, Shakir1 (AUTHOR), Farrash, Wesam F.1 (AUTHOR) |
| Source: | Journal of Biochemical & Molecular Toxicology. Jun2026, Vol. 40 Issue 6, p1-13. 13p. |
| Database: | Environment Complete |
| ISSN: | 10956670 |
|---|---|
| DOI: | 10.1002/jbt.70913 |
